Market Tracker

11/26 5:54am ET

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.6108
Data as of Nov 25
 -0.0124 / -1.99%
Today’s Change
0.53
Today|||52-Week Range
4.00
-33.97%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.62
Today’s open0.64
Day’s range-- - --
Volume167,097
Average volume (3 months)388,070
Market cap$39.1M
Dividend yield--
Data as of 11/25/2014

Growth & Valuation

Earnings growth (last year)+54.29%
Earnings growth (this year)-6.25%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.35

Competitors

 Today’s
change
Today’s
% change
PBMDPrima BioMed Ltd+0.02+1.94%
--Protea Biosciences G...0.000.00%
AEZSAEterna Zentaris Inc+0.00+0.48%
BCLIBrainstorm Cell Ther...-0.04-1.22%
Data as of 11/25/2014

Financials

Last reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Commercial Services
Industry
Miscellaneous Commercial Services
Chairman, Secretary &
Chief Scientific Officer
John S. Yu
President, Chief Executive Officer &
Director
Andrew Gengos
Corporate headquarters
Calabasas, California

Forecasts